Wegovy Pill (Oral Semaglutide)

Wegovy Pills Online UK

As of April 2026, high-dose oral semaglutide (often referred to as the "Wegovy pill") is NOT yet available on prescription in the UK for weight management. It was recently approved by the FDA and launched in the US in early 2026. It is currently under review by the UK’s MHRA and is expected to become available in the UK later in 2026.

Current Status: Pending
_{Awaiting final MHRA approval and NHS framework guidance.}

What is Wegovy Pill (Oral Semaglutide)

Wegovy pill is the new form of the Wegovy injection, which is available as a once-daily oral tablet. Promotes fat loss and metabolic improvements, not just temporary reductions in water or muscle mass. It can help improve blood sugar, cholesterol, and blood pressure, even in people without diabetes.

Novo Nordisk has successfully trialled a daily pill version of Wegovy (oral semaglutide) specifically for weight loss in 25mg and 50mg doses. Clinical trials indicate that the oral tablet can help users lose an average of 16.6% of their body weight. The medication also demonstrated significant individual success, with over 34% of fully adhering participants achieving a weight loss of 20% or greater. These results are highly comparable to the efficacy of the established weekly injection.

How does Wegovy pill work?

Wegovy belongs to a class of medications called GLP-1 receptor agonists. Delivers the same weight-loss power as the popular weekly injection. These work by mimicking a natural hormone that:

• Reduces appetite and targets brain regions involved in appetite regulation.
• Slows stomach emptying, which affects how quickly food passes through your system.
• Helps you feel full longer, leading to a decrease in overall calorie intake.

Wegovy pill contains semaglutide with an absorption enhancer (SNAC) that protects it from stomach acid. This allows the medication to be absorbed effectively when taken on an empty stomach with water, and to wait at least 30 minutes before eating or drinking anything else.

Clinical Efficacy: How Effective is the Oral Pill?

Recent clinical trials (OASIS 1 and OASIS 4) show that the new higher-dose oral semaglutide tablets (25 mg and 50 mg) are just as effective as the traditional 2.4 mg injection, delivering an average weight loss of 14% to 17% over 64 to 68 weeks.

• Proven Efficacy: Achieves up to 17% weight loss in patients with full treatment adherence, matching the established clinical outcomes of weekly injections.
• Consistent Results: Maintains a reliable 14% average weight loss under real-world conditions, even when accounting for occasionally missed doses.
• Significant Milestones: Over a third (34%) of patients who consistently maintained the 25 mg dose successfully lost at least 20% of their starting body weight.
• Comprehensive Health Benefits: Promotes enhanced physical mobility and assists in lowering key cardiovascular risk factors.
• Tolerability: Side effects are generally mild to moderate, predominantly gastrointestinal, and mirror the safety profile expected with injectable treatments.

Pill vs. Injection

Understanding the differences in administration can help you discuss options with your healthcare provider when the pill becomes available.

Oral Semaglutide (Pending)

• Taken daily as a tablet.
• Avoids needles entirely.
• Must be taken on an empty stomach with a small amount of water.
• Requires waiting 30 minutes before eating, drinking, or taking other medications.

Wegovy Injection (Available)

• Administered once weekly.
• Can be taken at any time, with or without food.
• Requires self-injection (subcutaneous).
• Currently available on private prescription and specific NHS tiers in the UK.

Wegovy pill dosages

The Wegovy (semaglutide) dose-escalation schedule is a structured, gradual process designed to help the body adjust to the medication and reduce gastrointestinal side effects.

Wegovy injections are increased every 4 weeks until the maintenance dose is reached. Wegovy pill (oral form) follows the same stepwise approach, starting from a lower dose and gradually increasing to a higher maintenance dose:

Prescribing Protocol: The Dose Escalation Schedule

Take one tablet daily at the same time each day.

_{Dose Tolerance and Missed Doses}

• _{If patients do not tolerate the 25 mg once-daily pill, consider switching to the once-weekly Wegovy® pen 1.7 mg.}
• _{Missed doses of the pill: Skip the missed dose and take the next scheduled dose the following day.}
• <sub>Important: Do not take more than one tablet per day.
  
  Disclaimer: Any adjustments to the Wegovy® dosing schedule should be determined by a healthcare professional based on individual tolerance and medical history.</sub>

Wegovy Tablets: Eligibility

Requirement: 

Wegovy tablets must be prescribed by a licensed healthcare professional following a clinical assessment. This includes reviewing your BMI, medical history, and any existing conditions.

Officially, Wegovy® pills are not yet available in the UK, so their suitability is not confirmed.
As of early 2026, the Wegovy® pill is FDA-approved and follows almost the same eligibility rules as the injection.

Who Can Be Eligible?

You may be considered for Wegovy if you are an adult and meet one of these criteria:

• BMI ≥30 (Obesity)
• BMI ≥27 (Overweight) plus at least one weight-related health issue, such as high blood pressure, high cholesterol, or Type 2 diabetes

Wegovy tablets cost in the UK

No official price for Wegovy tablets has been announced in the UK. In the US, they cost $149–$299 per month, with insurance or savings offers reducing this to as little as $25. Oral Wegovy is generally cheaper than the injection and other GLP-1 medications.